The disconnect between the share price and the hard facts is...

The disconnect between the share price and the hard facts is difficult, if I was to be honest, especially for those of us who have dug into the research.

The years 2017 and 2018 were tough years for FLC and harrowing for investors. At that early stage of MABR's life cycle, it was even a bit iffy for a period. Until iTest came.

While the share price has not performed remarkably, I hold onto the fact that one year ago, there was less than 10 reference sites around the world. But in a space of year, we now have 46 to 48 sites in China alone. If you add in ROW, there are more than 55 to 60 MABR reference sites for FLC alone. And if we the reference sites from Suez and Oxymem, we probably have 80. I mean, for a new tech trying to knock off an incumbent tech, it really has to climb a wall of scepticism. The rock is beginning to move.

The competitors cannot hold a candle to FLC. As a person of Chinese descent, I am really impressed that FLC has understood the complexities of the Chinese market, especially when some of us with the cultural affinity cannot even accomplish a quarter of what FLC has accomplished in 3 years what we tried 10 years to do. I mean, to break into Panjin City with a greenfield product, a 2nd tier city at that, albeit a very rich oil based economy, is a stroke of marketing genius. FLC went for a city that could afford SUBRE. To sweeten the deal, they threw in investments to the local economy, aiding local political reps hit the KPIs etc etc shows a depth of understanding of the Chinese way of doing biz. Take it from me, these guys at FLC are good.